PedAM
Pediatric Disease Annotations & Medicines
| Disease | pancreatitis |
| Symptom | C0011847|diabetes |
| Sentences | 52 |
| PubMedID- 21324812 | Conclusions: although incretin-based therapy effectively treats type 2 diabetes mellitus, emerging reports of acute pancreatitis in patients receiving sitagliptin and exenatide have prompted the us food and drug administration to issue an alert on these drugs. |
| PubMedID- 24674587 | Prophylactic effects of the glucagon-like peptide-1 analog liraglutide on hyperglycemia in a rat model of type 2 diabetes mellitus associated with chronic pancreatitis and obesity. |
| PubMedID- 23300896 | The adjusted odds ratio of acute pancreatitis in patients with diabetes mellitus was 1.86 (p<0.001) compared with non-diabetic patients in case-control analysis from 1,372 cases and 5,469 matched controls, which is consistent with the ones reported in previous studies. |
| PubMedID- 23700194 | reported a higher rate of hospitalizations for acute pancreatitis in patients with type 2 diabetes associated with the use of incretin-based therapies (sitagliptin or exenatide). |
| PubMedID- 21781351 | For further description see table 1. patients having diabetes as a consequence of known chronic pancreatitis, haemochromatosis, mutations in the insulin receptor, lipodystrophy, maturity-onset diabetes of the young, maternally inherited diabetes and deafness, family history of first-degree relatives with type 1 diabetes, insulin requirement within the first year after diabetes diagnosis or a fasting serum c-peptide level ≤ 150 pmol/l at time of recruitment were excluded from the category of clinically defined t2dm. |
| PubMedID- 22416857 | Recently, an observational study of pharmacy claims evaluated the risk of acute pancreatitis among patients with and without diabetes and among patients treated with exenatide twice daily, sitagliptin or control diabetes medications. |
| PubMedID- 21701614 | Given the baseline rate of pancreatitis in people with diabetes, it is currently difficult to know if reports of pancreatitis in people on incretin therapies are truly attributable to drug usage. |
| PubMedID- 20217037 | Aims/hypothesis: diabetes frequently develops in patients with chronic pancreatitis (cp). |
| PubMedID- 21525466 | Up-to-date observational reports and clinical study data revealed that 44 cases of acute pancreatitis occurred in patients with type 2 diabetes while taking exenatide (8 cases during clinical development and 36 postmarketing reports), 4 cases of pancreatitis in liraglutide-treated patients (in clinical trials), and none during therapy with albiglutide or taspoglutide (51). |
| PubMedID- 21577242 | Objectives: the objective of this study was to assess the risk of acute pancreatitis among patients with type 2 diabetes mellitus (dm) and identify the roles of co-morbidities and anti-diabetic drugs. |
| PubMedID- 22923278 | Aim: to determine oxidant stress and antioxidant capacity in chronic pancreatitis (cp) patients with and without diabetes mellitus. |
| PubMedID- 20682680 | Figure 1 shows the kaplan-meier curve of time to acute pancreatitis in patients with diabetes compared with that in nondiabetic control patients. |
| PubMedID- 21822421 | diabetes mellitus associated with autoimmune pancreatitis can be treated by steroids, and it can even be cured if the autoimmune attack can be stopped . |
| PubMedID- 21437074 | This is difficult to establish because there is a generalized increased risk of acute pancreatitis in patients with diabetes, obesity or hyperlipemia. |
| PubMedID- 25401425 | diabetes increases pancreatitis induced systemic inflammation but has little effect on inflammation and cell death in the lung. |
| PubMedID- 20375642 | Serum hbsag and anti-hcv were examined, and data on smoking, alcohol intake, diabetes, and the history of chronic pancreatitis (cp) were collected. |
| PubMedID- 22588243 | The following clinical data were extracted from patient case records: age, gender, diabetes mellitus, history of chronic pancreatitis, autoimmune disease, smoking, alcohol consumption, jaundice, weight loss, and pain. |
| PubMedID- 24764569 | As incretin based drugs are typically second to third line drugs2 and the risk of acute pancreatitis increases with type 2 diabetes and possibly with duration of disease,404142 it is imperative that they are compared with drugs used at the same or a similar stage of diabetes, otherwise this would introduce a time lag bias.43 it is for this reason that our primary comparator group consisted of sulfonylurea users, which we believe is the clinically most appropriate comparator. |
| PubMedID- 25528851 | The severity of chronic pancreatitis with concomitant diabetes was deeper than in the patients without endocrine failure: respectively, the average severity (s) prevailed in 72.7% of patients vs 25%, the cases of expressed and severe severity appeared. |
| PubMedID- 19894028 | In one such study, the incidence of pancreatitis was increased in patients with type 2 diabetes treated with the glp-1 analogue liraglutide . |
| PubMedID- 20833867 | Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study. |
| PubMedID- 20096519 | Complete resolution of insulin-dependent diabetes mellitus in a patient with autoimmune pancreatitis following treatment with corticosteroids. |
| PubMedID- 21994885 | Weight loss or new-onset diabetes mellitus due to pancreatitis is another potential symptom. |
| PubMedID- 23882053 | Other studies have examined lipase and amylase activities in serum (20) and the incidence of acute pancreatitis in patients with type 2 diabetes while receiving different forms of antidiabetes treatment (21–26). |
| PubMedID- 20412332 | The incidence of pancreatitis is increased in patients with type 2 diabetes (t2dm), and cases of pancreatitis have been reported in patients using most categories of antihyperglycemic medications. |
| PubMedID- 23269874 | In recent years, postmarketing safety surveillance has raised concerns about the risk of pancreatitis in patients with type 2 diabetes who receive antidiabetic therapies. |
| PubMedID- 26512613 | To investigate the effects of dipeptidyl peptidase-4 (dpp-4) inhibitors on the risk of acute pancreatitis in patients with type 2 diabetes.this nationwide population-based cohort study used the diabetes patients dataset of taiwan's national health research insurance research database. |
| PubMedID- 25918533 | If pancreatic autoantibodies are negative, patients have secondary diabetes due to pancreatitis or type 2 diabetes complicated by acute pancreatitis. |
| PubMedID- 20182396 | Among true pancreatic diabetes with chronic pancreatitis, alcoholic pancreatitis was found in the largest sector. |
| PubMedID- 21175494 | A 63-year-old woman was admitted for endoscopic treatment of acute on chronic pancreatitis with diabetes and epigastric pain with liver dysfunction due to a large impacted stone within the distal main pancreatic duct. |
| PubMedID- 24736555 | Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies. |
| PubMedID- 23136562 | His pancreatitis was complicated with type ii diabetes that required insulin treatment for the last 4 years. |
| PubMedID- 24859164 | Acute pancreatitis in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase-4 inhibitors: a population-based nested case-control study. |
| PubMedID- 24651798 | That study used a large insurance database of more than 1 million people, and reported increased odds of hospitalizations for acute pancreatitis in patients with type 2 diabetes 64 years of age or younger that were prescribed either exenatide or saxagliptin. |
| PubMedID- 23170157 | Short and long-term outcomes of diabetes mellitus in patients with autoimmune pancreatitis after steroid therapy. |
| PubMedID- 24571389 | In order to find a more reliable biomarker or biomarker panel,several pancreatic cancer related disease states (diabetes, cysticneoplasms of the pancreas, chronic pancreatitis, and obstructive jaundice)along with healthy controls were compared with pancreatic cancer patients.lectin extraction and quantitative proteomics methods were appliedto discover potential serum glycoprotein biomarkers that distinguishpancreatic cancer from the other groups. |
| PubMedID- 21180276 | Of all the 12 patients with ipmn, 9 (75.0%) had experienced some symptoms of epigastric discomfort and/or pain as well as backache; 7 cases were with medical history of acute pancreatitis, 5 cases with diabetes, 4 cases with elevated ca19-9, and 2 cases with steatorrhea. |
| PubMedID- 23139373 | A recent observational study found a threefold increased risk of pancreatitis in patients with type 2 diabetes (14), making any assessment of causality difficult in this relatively small study. |
| PubMedID- 22230860 | We are reporting a case of dengue hemorrhagic fever complicated by acute pancreatitis in a patient with history of diabetes mellitus type 1 and end stage renal disease on hemodialysis. |
| PubMedID- 24711951 | We report a case of a patient who clinically presented with acute manifested diabetes mellitus associated with isolated granulomatous pancreatitis discovered in the postmortem examination and we present a review of the available literature. |
| PubMedID- 22687379 | Background: the co-existence of diabetes mellitus (dm) in patients with acute pancreatitis (ap) is linked to poor outcomes. |
| PubMedID- 22121010 | Thus, diabetes mellitus due to chronic pancreatitis occurred in this collective in 7.2% of all diabetic subjects. |
| PubMedID- 20103558 | Notably, analysis of pancreatitis in subjects with type 2 diabetes suggests that their risk is increased threefold over nondiabetic subjects (21). |
| PubMedID- 24251162 | diabetes due to recurrent pancreatitis secondary to hypercalcemia due to primary hyperparathyroidism. |
| PubMedID- 26125315 | There is increasing evidence suggesting an increased risk for (pancreatic) cancer and pancreatitis in patients with diabetes mellitus. |
| PubMedID- 23522174 | pancreatitis can lead to development of diabetes mellitus, which may be transient (diabetic remission) or permanent through destruction and loss of beta cells. |
| PubMedID- 24661305 | Incidence and precipitants of hospitalization for pancreatitis in people with diabetes: the fremantle diabetes study. |
| PubMedID- 22410797 | Another patient developed necrotizing pancreatitis with transient diabetes mellitus 10 years after first presentation, for which a partial pancreatectomy was performed. |
| PubMedID- 19703814 | Objective: to report acute pancreatitis in a patient with non-insulin-dependent diabetes mellitus (niddm) receiving exenatide and critically review previous reports. |
| PubMedID- 24217090 | There is increasing concern about the development of pancreatitis in patients with diabetes mellitus who received long-term glucagon-like peptide-1 (glp-1) analog treatment. |
Page: 1 2